Warfarin anticoagulation: a survey of patients' knowledge of their treatment

Ir J Med Sci. 2011 Dec;180(4):819-22. doi: 10.1007/s11845-011-0726-0. Epub 2011 Jun 25.

Abstract

Introduction: Warfarin is used for the treatment of thromboembolic disease. It requires careful and sustained monitoring due to its narrow therapeutic index and potentially life-threatening complications. Patient education and knowledge is, therefore, vital.

Aims: To assess, in a specialised anticoagulation clinic, the extent of patients' knowledge of their warfarin treatment.

Methods: Ethical approval was obtained. All patients, aged over 18 years, attending our anticoagulation clinic during our study period were asked to participate.

Results: We enrolled 181 patients, 47.9% of respondents were unaware of any potential drug interactions, 57.7% of patients were unaware of any potential side effects, 20% of patients had experienced side effects, 10.9% of patients had been hospitalised due to side effects, 58% of which were due to Haemorrhage and 79% of patients kept a personal record of their INR.

Conclusions: Patients' understanding of warfarin treatment was poor, despite their high level of compliance.

MeSH terms

  • Aged
  • Aged, 80 and over
  • Anticoagulants / adverse effects
  • Anticoagulants / therapeutic use*
  • Female
  • Health Knowledge, Attitudes, Practice*
  • Humans
  • Male
  • Medication Adherence
  • Middle Aged
  • Patient Education as Topic
  • Surveys and Questionnaires
  • Warfarin / adverse effects
  • Warfarin / therapeutic use*

Substances

  • Anticoagulants
  • Warfarin